Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique gene...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Dana-Farber Cancer Institute
NCT06299540 · Leukemia, Lymphocytic, Chronic, B-Cell
NCT05735717 · Hematologic Malignancy, Acute Leukemia, and more
NCT06667687 · Non-Hodgkin's Lymphoma
NCT07162181 · Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, and more
NCT04664179 · EBV-Related Hodgkin Lymphoma, EBV-Related Lymphoproliferative Disorder, and more
Dana-Farber Cancer Institute
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions